Share this link via:
The drug discovery process is long and costly, and therefore pharmaceutical firms need to spend money on the most effective and efficient tools to aid them the drug discovery process informatics is one of these methods that is easy and rapid for researchers to identify potential drug targets and design new therapies. Informatics has become central to the discovery process due to increased use of big data. In the next decade, job growth is expected to be fueled by growing demand for drug discovery informatics professionals. The job prospects are also expected to be good because of growing usage of outsourcing among big pharma companies.
Job opportunities for drug discovery informatics experts will increase by 21 percent between 2021 and 2027, more than double the average rate of all occupations, as per the BLS. The expansion arrives as pharmaceutical industries continue to reel from excessive expense and scarce substitutes for the cure of some disease. Yet highly qualified people have plenty of scope in this fast-growing industry.
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Drug Discovery Informatics Market. On the basis of historic growth analysis and current scenario of Drug Discovery Informatics market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Drug Discovery Informatics market. This further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Drug Discovery Informatics market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Drug Discovery Informatics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.
The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The new chemical entity and data convenience from multiple sources rely on drug discovery informatics for sequencing analysis. The management of sequence data can be cumbersome and time consuming if not handled correctly. Thus, key end-users are making it a point to utilize informatics tools to enhance the efficiency and quality of work. Correct annotation and curation of the data are essential for analysis. Data handling of the sequencing data is critical. The application of informatics tools can assist in enhancing the quality and efficiency of the work. The application of software like EMBOSS can assist in automating most of the work involved in the sequencing analysis. The software can assist in enhancing the accuracy of the outcome and shorten the time required for the analysis.
In addition, the demand for different tools and software is growing rapidly in the drug discovery informatics industry as they can improve the caliber and efficiency of work performed on the data produced by next-generation sequencing. With increasing automation in labs, high throughput assays are increasingly being utilized; however, it may be difficult to analyze the large volumes of data generated by these assays. This process could be made easier, and the data quality produced better using informatics technologies. While next-generation sequencing analysis involves a lot of resources, this work can be done quicker through the help of informatics tools.
are a few of the major players in the drug discovery informatics market.
The discipline of drug discovery informatics has increased dramatically in recent years. This method is being utilized by pharmaceutical firms to accelerate their drug discovery processes. It allows researchers to store and analyze data in a better manner, which can lead to more precise research results, faster discovery of new drug targets, faster drug discovery turnaround times, and the ability to examine more data than with conventional methods.
In the beginning, scientists used to manage the information related to experiments on spreadsheets, which required a lot of time and involved errors. Researchers can now acquire, store, analyze, and visualize research information on databases especially designed for it with the aid of software applications such as Bioconductor, Taverna Workbench, and KNIME owing to the progression in drug discovery informatics technology.
Pharmaceutical firms in the global drug discovery informatics market are rapidly understanding the value of drug discovery informatics and are investing heavily in this technology. For instance, GlaxoSmithKline (GSK) has established a special Informatics Research Centre that applies informatics to assist in identifying new drug targets and designing molecules to target those targets. The center has more than 1000 employees and a budget of more than $200 million. GSK does not stand alone; other pharma players like Roche, AstraZeneca and Merck are investing extensively in drug discovery informatics.
The report also helps in understanding Global Drug Discovery Informatics Market dynamics, structure by analyzing the market segments, and project the Global Drug Discovery Informatics Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Drug Discovery Informatics Market make the report investor’s guide.
North America accounted for the highest xx% market share in terms of revenue in the Drug Discovery Informatics market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Drug Discovery Informatics. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Drug Discovery Informatics companies in economies such as Japan and China.
Given that it is the most technologically developed part of the world, North America has been at the forefront of influencing the drug discovery informatics market. On top of this, there has been a high number of players in the industry, resulting in productive product and technology developments. With deep penetration of the technologies in SMEs, there is potential for a great opportunity for SMEs. Government initiatives have also created new employment opportunities for informatics experts.
There are several well-established CROs in the region, which is fuelling the need for informatics solutions. The pharmaceutical and biopharmaceutical companies in the region are also increasing their research and development spending. Some of the significant CROs include Parexel, Quintiles, Covance, Charles River Laboratories, CRI Worldwide, ICON plc, and Icon Clinical Research, and they are based in North America. The expansion of drug discovery informatics services in the region is also driven by the presence of key clients such as Roche Diagnostics (US), Pfizer (US), Merck & Co. (US), and Eli Lilly and Company (US). Additionally, strong government support for R&D activities is also driving the expansion of the market in North America. For instance, the National Institutes of Health (NIH) of the United States of America spent approximately $37.5 billion on healthcare-associated research only, which is likely to drive the growth of the drug discovery informatics market within the region during 2025-2034.
To broaden their footprint geographically, major players of the North American drug discovery informatics market were seen to develop a focus towards collaborative initiatives as well as strategic alliances with native as well as overseas firms. For instance, Parexel, in March 2016, established a strategic alliance with WuXi AppTec-based China to present strengthened services in China. This alliance will probably allow the companies to benefit from the increasing demand for drug discovery and development services in China.
The objective of the report is to present comprehensive analysis of Global Drug Discovery Informatics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Drug Discovery Informatics Market Report is also available for below Regions and Country Please Ask for that
Drug Discovery Informatics Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
14 Jun 2022
Intellectual Market Insights Research © 2025. All rights reserved.
